50. 皮膚筋炎/多発性筋炎 Dermatomyositis Clinical trials / Disease details
臨床試験数 : 182 / 薬物数 : 229 - (DrugBank : 88) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 147
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02245841 (ClinicalTrials.gov) | June 15, 2015 | 11/9/2014 | Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis | Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis | Dermatomyositis;Juvenile Dermatomyositis | Drug: H.P. Acthar Gel | The Cleveland Clinic | Mallinckrodt | Completed | 18 Years | N/A | All | 15 | Phase 4 | United States |
2 | NCT01906372 (ClinicalTrials.gov) | September 2013 | 5/7/2013 | Acthar in Treatment of Refractory Dermatomyositis and Polymyositis | Open Label Proof of Concept Study to Evaluate Efficacy and Safety of Adrenocorticotropic Hormone Gel in Refractory Dermatomyositis or Polymyositis | Dermatomyositis;Polymyositis | Drug: Adrenocorticotropic Hormone Gel | Rohit Aggarwal, MD | Mallinckrodt | Completed | 18 Years | N/A | All | 12 | Phase 2 | United States |
3 | NCT01637064 (ClinicalTrials.gov) | April 2013 | 6/7/2012 | Dermatomyositis and Polymyositis Registry | Acthar Dermatomyositis and Polymyositis Treatment | Dermatomyositis;Polymyositis | Drug: Acthar | Phoenix Neurological Associates, LTD | NULL | Enrolling by invitation | 18 Years | 85 Years | Both | 100 | N/A | United States |